• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제26권2호
• /
• pp.179-185
• /
• 2000

The purpose of this study was to develop an osteogenic, biodegradable material using polymer and BMP. It was designed to have structural function and be moldable, for the reconstruction of load bearing areas and deformities of various configurations. Bone apatite was added to Poly(L-lactide)(PLLA) and made porous for osteoconductability and ease of BMP loading. The materials, with or without BMP purified from porcine bone matrix, were evaluated in cranial bone defect models in rats for biocompatibility and bone regeneration capability. The following results were obtained: The PLLA-BMP material with BMP added to the polymer showed 30% healing of cranial bone defects in rats during the 2 weeks to 3 months period of observation. The moldable PLLA agent without BMP also showed 25% bone healing capacity. Although new bone formation was incomplete in the critical size defect of rat cranium, it can be concluded that the unique moldability of those agents makes them useful for the reconstruction of various bone defects and maxillofacial deformities.

• Journal of Pharmaceutical Investigation
• /
• 제34권2호
• /
• pp.101-106
• /
• 2004

This work aims at examining the cellular uptake behavior of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles derivatized with a protein transduction domain (PTD) using HeLa cells. For this purpose, $Tat_{49-57}$ peptide derived from transcriptional activation (Tat) protein of HIV type-1 was covalently conjugated to the terminal end of PLGA. Nanoparticles were ten prepared with the $Tat_{49-57}-PLGA$ conjugates by a spontaneous phase inversion method. The prepared particles had a mean diameter of ca. 84 nm, as measured by dynamic light scattering. The interaction of the Tat-PLGA nanoparticles with cells was examined by using confocal laser scanning microscopy. It was found tat Tat-PLGA nanoparticles incubated with HeLa cells could efficiently translocate into cytoplasm, while plain PLGA nanoparticles showed negligible cellular uptake. In addition, even at $4^{\circ}C$ or in the presence of sodium azide significant cellular internalization of Tat-PLGA nanoparticles was still observed. These results indicate that a non-endocytotic translocation mechanism might be involved in the cellular uptake of Tat-PLGA nanoparticles.

• Macromolecular Research
• /
• 제8권2호
• /
• pp.80-88
• /
• 2000

Biodegradable microspheres were prepared with poly(L-lactide-co-glycolide) (PLGA, 75 : 25 by mole ratio) by an oil/oil solvent evaporation method for the sustained release of anti-AIDS virus agent, AZT The microspheres of relatively narrow size distribution (7.6$\pm$ 3.8 ㎛) were obtained by controlling the fabrication conditions. The shape of microspheres prepared was smooth and spherical. The efficiency of AZT loading into the PLGA microsphere was over 93% compared to that below 15% for microspheres by a conventional water/oil/water method. The effects of Preparation conditions on the morphology and in vitro AZT release pattern were investigated. in vitro release studies showed that different release pattern and release rates could be achieved by simply modifying factors in the fabrication conditions such as the type and amount of surfactant, initial amount of loaded drug, the temperature of solvent evaporation, and so on. PLCA microspheres prepared by 5% of initial drug loading, 1.0% (w/w) of surfactant concentration, and 25$\^{C}$ of solvent evaporation temperature were free from initial burst effect and a near-zero order sustained release was observed. Possible mechanisms of the near-zero order sustained release for our system have been proposed.

• 폴리머
• /
• 제25권3호
• /
• pp.385-390
• /
• 2001

oxyethylene/oxypropylene 공중합체의 존재하에 L-lactide를 중합시킴에 의해 poly(L-lactic acid) (PLLA) (A)와 polyether (B)로 이루어진 A-B-A block copoly(ester-ether)를 합성하였으며, 이들 블록 공중합체는 세그멘트를 도입함에 의해 PLLA에 유연성이 부여되었고, 표면에서의 미세상분리 구조로 인한 항혈전성의 개질을 확인하기 위하여 AFM사진을 관찰한 결과, PLLA와 비교하여 블록 공중합체는 필름표면의 요철성이 현저하게 저하하여 매끄러운 것을 확인하였으며 따라서, 표면의 요철이 항혈전성의 증가와 깊은 관계가 있음을 확인하였다.

• Macromolecular Research
• /
• 제17권8호
• /
• pp.575-579
• /
• 2009

Copolymerization of L-lactide and s-caprolactone initiated by tin (II) octoate (Sn(Oct)$_2$) was carried out in supercritical chlorodifluoromethane (R22) with varying reaction conditions (time and temperature) and amounts of monomer and catalyst, under a pressure of 250 bar. The optimum conditions were a reaction time of 10 h and a temperature of 130 $^{\circ}C$, which is similar to the temperature used in bulk copolymerization system. The conversion increased from 56% to 76% by increasing the reaction time from 1 to 10 h. The molecular weight also increased to 75,900 g.mol$^{-1}$ over the same period, while the increased monomer concentration resulted in a high molecular weight of 86,400 g.mol$^{-1}$ and a monomer conversion of 84%. Raising the reaction temperature from 90 to 130 $^{\circ}C$ increased the monomer conversion as well as the poly-L-lactide-co-${\varepsilon}$-caprolactone (PLCL) molecular weight. The variation on the stannous octoate catalyst suggested that less catalyst would decrease the caprolactone content of the polymer.

• 한국고분자학회:학술대회논문집
• /
• 한국고분자학회 2006년도 IUPAC International Symposium on Advanced Polymers for Emerging Technologies
• /
• pp.210-211
• /
• 2006

A series of L-LA polymerizations initiated by $Sn(Oct)_{2}\;([LA]_{0}/[Sn]_{0}=200)$ were carried out in scR22 at $130^{\circ}C$ and 300 bar, where $[LA]_{0}$ is the initial L-lactide concentration and $[Sn]_{0}$ is the initial $Sn(Oct)_{2}$ concentration. The reaction time dependences of monomer conversion and PLLA MW improved. The monomer conversion and PLLA MW increased with increasing reaction time. The effect of temperature on monomer conversion and PLLA MW was investigated in a series of polymerizations conducted at temperatures ranging from 90 to $150^{\circ}C$ and at a constant pressure of 200 bar. In all of these experiments, the ratio of monomer to R22 concentration was held constant at 12.4 wt.-%. Increasing the reaction temperature from 90 to $130^{\circ}C$ resulted in increased monomer conversion from 11.5 to 72.2 %.

• 폴리머
• /
• 제32권2호
• /
• pp.143-149
• /
• 2008

생체적합성을 가진 친수성 poly(ethylene glycol)(PEG)블록과 생분해성 고분자인 Poly(D,L-lactide)(PLA) 또는 poly(lactide-co-glycolide)(PLGA)를 소수성 블록으로 하는 양친성 이중 블록공중합체를 합성하여 난용성 당뇨병 치료제인 pioglitazone의 가용화를 위한 고분자 미셀을 제조하였다. PEG 말단으로부터 LA의 개환중합에 의해 합성된 고분자의 화학적 조성과 분자량은 반응액 내 당량비로 조절하였고, 합성된 고분자는 수용액 상에서 $10{\sim}30\;nm$ 크기인 구형의 자기조립 미셀을 형성하였다($CMC=0.001{\sim}0.0076\;mg/mL$). 투석법과 고체분산법을 이용하여 약물을 봉입한 후 AFM, DLS, HPLC 분석을 통하여 미셀의 특성을 비교하였다. 결론적으로 PEG-PLA(또는 PLGA) 공중합체를 이용한 고체분산법을 통해 pioglitazone을 효과적으로 가용화시킬 수 있었다.

• 한국산학기술학회논문지
• /
• 제13권11호
• /
• pp.5595-5600
• /
• 2012

본 논문은 poly(lactic acid)의 내열성을 향상시키기 위한 결정화 핵제의 검토 및 연구에 대한 것이다. 네 종류의 미세분말 핵제인 금속염 2,2'-methylene bis(4,6-di-tert-butylphenol) salt를 결정화 핵제로 사용하였다. 폴리머 컴파운드의 열적 및 기계적 특성은 DSC, HDT, UTM을 통해 측정하였다. 이 연구의 결과로서, 컴파운드 한 폴리머 샘플들의 내열특성은 핵제의 함량 증가와 미세분말 일수록 선형적으로 증가 하였다. 그 중에서MPZ2의 함량이 2 wt%일때 가장 높은 내열특성을 나타내었으며, PL98Z2 컴파운드의 열변형 온도는 $116^{\circ}C$를 나타내었다 (ASTM D 648, 0.455MPa).

• 폴리머
• /
• 제31권1호
• /
• pp.20-24
• /
• 2007

제조과정에서 단백질 약물의 생물학적 활성의 보존은 약물의 성공적인 전달에 있어 여전히 중요한 과제이다. 이중에멀션 유기용매 증발법을 사용하여 나노입자를 제조하였고, 입자의 형태, 크기, 함입률 그리고 방출속도와 방출되는 효소의 활성을 살펴보았다. 입자의 크기는 고분자인 락타이드 글리콜라이드 공중합체의 농도가 증가할수록 커졌으며, 유화제의 농도에는 큰 차이가 없었으나, 4% PVA의 사용에서 가장 좁은 입자분포를 얻을 수 있었다. 최적의 조건에서 72.6%의 단백질 함입률과 $198.3{\pm}13.8 nm$ 크기의 나노입자를 얻었다. 입자로부터 효소의 방출은 첫 방출시기에 매우 빠르게 일어났으며 12일 내에 83%가 방출되었다. 이에 따른 방출되는 효소의 활성은 6일째까지 증가되었다.

• 폴리머
• /
• 제34권6호
• /
• pp.527-533
• /
• 2010

Pioglitazone을 봉입한 poly(lactide-co-glycolide)(PLGA) 나노입자를 emulsion-evaporation 방법을 이용하여 제조하여 최적의 나노입자와 봉입률을 조절하였다. 제조된 나노입자의 크기는 125~170 nm이었으며 30% pioglitazone이 봉입된 나노입자(3% PVA)의 봉입률은 85% 이상이었다. 이러한 나노입자들은 40일 동안 일정하게 용출이 되었다. 당뇨병 모델을 이용한 동물실험에서 글루코오스 농도를 저하시켰을 뿐만 아니라, 조직검사에서는 낮은 독성을 가지고 있는 것을 확인하였다. 이러한 결과는 pioglitazone 경구투여를 위한 약물전달을 위한 운반체로 사용될 수 있음을 확인하였다.